Specific incorporation of cyclophilin A into HIV-1 virions
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Little is known about host factors necessary for retroviral virion assembly or uncoating. We have previously shown that the principal structural protein of the human immunodeficiency virus HIV-1, the Gag polyprotein, binds the cyclophilin peptidyl-prolyl isomerases; cyclophilins catalyse a rate-limiting step in protein folding and protect cells from heat shock. Here we demonstrate that cyclophilin A is specifically incorporated into HIV-1 virions but not into virions of other primate immunodeficiency viruses. A proline-rich region conserved in all HIV-1 Gag polyproteins is required for cyclophilin A binding and incorporation. Disruption of a single proline blocks the Gag-cyclophilin interaction in vitro, prevents cyclophilin A incorporation into virions, and inhibits HIV-1 replication. Our results indicate that the interaction of Gag with cyclophilin A is necessary for the formation of infectious HIV-1 virions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The CA-NTD contains six to seven alphahelices and in some viruses a flexible loop region implicated in binding of cellular host factors”
From Retrovirus maturation-an extraordinary structural transformation (2016) · cites this paper as [15]
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., & Martin, M. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,834
Human Retroviruses and Aids - 1999
Kuiken, C., & Foley, B. (1999) · doi:10.2172/1186019 · Cited by 952
Genome organization and transactivation of the human immunodeficiency virus type 2
Guyader, M., Emerman, M., Sonigo, P., Clavel, F., Montagnier, L., & Alizon, M. (1987) · Nature · doi:10.1038/326662a0 · Cited by 848
[71] Use of eukaryotic expression technology in the functional analysis of cloned genes
Cullen, B. R. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)52074-2 · Cited by 822
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B
Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V., & Goff, S. P. (1993) · Cell · doi:10.1016/0092-8674(93)90637-6 · Cited by 802
Self-citationInduction of AIDS in Rhesus Monkeys by Molecularly Cloned Simian Immunodeficiency Virus
Kestler, H., Kodama, T., Ringler, D., Marthas, M., Pedersen, N., Lackner, A., Regier, D., Sehgal, P., Daniel, M., King, N., et al. (1990) · Science · doi:10.1126/science.2160735 · Cited by 514
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus
(1992) · Infectious Diseases Newsletter · doi:10.1016/0278-2316(92)90022-6 · Cited by 497
Friedman, J., & Weissman, I. (1991) · Cell · doi:10.1016/0092-8674(91)90123-g · Cited by 395
Paxton, W., Connor, R. I., & Landau, N. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7229-7237.1993 · Cited by 371
Research works printed but not linked: 1
- Field, J. et al. Molec cell. Biol. 8, 2159–2165 (1988). · doi:10.1128/mcb.8.5.2159 · Paper page
Cited by
Items 301–400 of 749
Nef enhances HIV-1 infectivity via association with the virus assembly complex
Qi, M., & Aiken, C. (2008) · Virology · doi:10.1016/j.virol.2007.12.001 · Cited by 40
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules
Saito, A., & Yamashita, M. (2021) · Retrovirology · doi:10.1186/s12977-021-00577-x · Cited by 44
Heat shock proteins: novel therapeutic tools for HIV-infection?
BRENNER, B. G., & Wainberg, Z. A. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.1.67 · Cited by 40
Immunophilins and HIV-1 V3 Loop For Structure-Based Anti-AIDS Drug Design
Andrianov, A. M. (2009) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2009.10507259 · Cited by 40
Mlynar, E., Rosenwirth, B., Steinkasserer, A., Bevec, D., & Billich, A. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-4-825 · Cited by 41
Cyclophilin A inhibits rotavirus replication by facilitating host IFN-I production
He, H., Zhou, D., Fan, W., Fu, X., Zhang, J., Shen, Z., Li, J., Li, J., & Wu, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.050 · Cited by 38
Edlich, F., & Fischer, G. S. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-29717-0_15 · Cited by 42
Qian, Z., Zhao, X., Jiang, M., Jia, W., Zhang, C., Wang, Y., Li, B., & Yue, W. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-442 · Cited by 39
Prolyl isomerases in a minimal cell
Bang, H., Pecht, A., Raddatz, G., Scior, T., Solbach, W., Brune, K., & Pahl, A. M. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01355.x · Cited by 39
Chakraborty, A., Das, I. R., Datta, R., Sen, B., Bhattacharyya, D., Mandal, C., & Datta, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204827200 · Cited by 38
Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5α
Li, X., Song, B., Xiang, S.-H., & Sodroski, J. (2007) · Virology · doi:10.1016/j.virol.2007.04.022 · Cited by 48
Schmidt, B., Tradler, T., Rahfeld, J., Ludwig, B., Jain, B., Mann, K., RÜCKNAGEL, K. P., Janowski, B., Schierhorn, A., Küllertz, G., et al. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.00061.x · Cited by 39
Structures of cyclophilin-ligand complexes
Taylor, P., Husi, H., Kontopidis, G. A., & Walkinshaw, M. D. (1997) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(97)00014-x · Cited by 39
Capsid–host interactions for HIV-1 ingress
Jang, S., & Engelman, A. (2023) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00048-22 · Cited by 42
Gallay, P. A., Bobardt, M. D., Chatterji, U., Trepanier, D. J., Ure, D., Ordonez, C., & Foster, R. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134707 · Cited by 39
Modular HIV-1 Capsid Assemblies Reveal Diverse Host-Capsid Recognition Mechanisms
Summers, B. J., Digianantonio, K. M., Smaga, S., Huang, P.-T., Zhou, K., Gerber, E. E., Wang, W., & Xiong, Y. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.07.007 · Cited by 39
Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase
Heck, J. A., Meng, X., & Frick, D. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.019 · Cited by 50
The role of Vif during HIV-1 infection: interaction with novel host cellular factors
Lake, J.-A., Carr, J. M., Feng, F., Mundy, L. M., Burrell, C. J., & Li, P. (2003) · Journal of Clinical Virology · doi:10.1016/s1386-6532(02)00113-0 · Cited by 38
FKBP12 Physically and Functionally Interacts with Aspartokinase in Saccharomyces cerevisiae
Alarcón, C. M., & Heitman, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5968 · Cited by 44
Towards the structure of the human immunodeficiency virus: divide and conquer?
Wilk, T., & Fuller, S. D. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80033-5 · Cited by 46
Sayah, D. M., & Luban, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12066-12070.2004 · Cited by 38
Self-citationCheng, S., Luo, M., Ding, C., Peng, C., Lv, Z., Tong, R., Xiao, H., Xie, H., Zhou, L., Wu, J., et al. (2016) · Gene · doi:10.1016/j.gene.2016.07.020 · Cited by 37
Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
Li, X., & Peng, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.660710 · Cited by 43
Kameoka, M., Rong, L., Götte, M., Liang, C., Russell, R. S., & Wainberg, M. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2675-2683.2001 · Cited by 42
Hansson, M. J., Moss, S. J., Bobardt, M. D., Chatterji, U., Coates, N., Garcia-Rivera, J. A., Elmér, E., Kendrew, S. G., Leyssen, P., Neyts, J. H., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.10.023 · Cited by 37
Song, C., & Aiken, C. (2007) · Journal of Virology · doi:10.1128/jvi.00620-07 · Cited by 37
Dochi, T., Nakano, T., INOUE, M., Takamune, N., Shoji, S., Sano, K., & Misumi, S. (2014) · Journal of General Virology · doi:10.1099/vir.0.060053-0 · Cited by 40
Martin, L. N., Murphey‐Corb, M., MACK, P. A., Baskin, G. B., Pantaleo, G., Vaccarezza, M., Fox, C. H., & Fauci, A. S. (1997) · The Journal of Infectious Diseases · doi:10.1086/514054 · Cited by 37
Viral and cellular factors that regulate HIV-1 uncoating
Aiken, C. (2006) · Current Opinion in HIV and AIDS · doi:10.1097/01.coh.0000221591.11294.c1 · Cited by 42
Li, J., Chen, J., Zhang, L., Wang, F., Gui, C., Zhang, L., Qin, Y., Xu, Q., Liu, H., Nan, F., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.04.026 · Cited by 39
Fine Specificity and Cross-Clade Reactivity of HIV Type 1 Gag-Specific CD4 + T Cells
Norris, P. J., Moffett, H. F., Brander, C., Allen, T. M., O'Sullivan, K. M., Cosimi, L. A., Kaufmann, D., Walker, B. D., & Rosenberg, E. S. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322996554 · Cited by 41
Determinants of cyclophilin A-dependent TRIM5α restriction against HIV-1
Lin, T., & Emerman, M. (2008) · Virology · doi:10.1016/j.virol.2008.06.037 · Cited by 42
McCarthy, K. R., Kirmaier, A., Autissier, P., & Johnson, W. E. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005085 · Cited by 38
Wang, L., Casey, M. C., Vernekar, S. K. V., Sahani, R. L., Kirby, K. A., Du, H., Zhang, H., Tedbury, P. R., Xie, J., Sarafianos, S. G., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.016 · Cited by 36
Human Ubc9 Contributes to Production of Fully Infectious Human Immunodeficiency Virus Type 1 Virions
Jaber, T., Bohl, C. R., Lewis, G. L., Wood, C. A., West, J. T., & Weldon, R. A. (2009) · Journal of Virology · doi:10.1128/jvi.00237-09 · Cited by 38
Rits, M. A. N., van Dort, K. A., & Kootstra, N. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003975 · Cited by 35
Padwad, Y. S., Mishra, K. P., Jain, M., Chanda, S., Karan, D., & Ganju, L. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.010 · Cited by 36
Long-Term Follow-up of HIV Positive Asymptomatic Patients Having Received Cyclosporin A
Lévy, R., Jaïs, J., Tourani, J. M., Even, P., & Andrieu, J. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1995-9_20 · Cited by 36
Laurent, L. C., Olsen, M. N., Crowley, R. A., Savilahti, H., & Brown, P. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2760-2769.2000 · Cited by 40
Novel Bicyclic Lactams as XaaPro Type VI β Turn Mimics: Design, Synthesis, and Evaluation
Kim, K., Dumas, J., & Germanas, J. P. (1996) · The Journal of Organic Chemistry · doi:10.1021/jo960012w · Cited by 35
Dolinski, K., Scholz, C., Muir, R. S., Rospert, S., Schmid, F. X., Cardenas, M. E., & Heitman, J. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.11.2267 · Cited by 35
Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5α
Pacheco, B., Finzi, A., Stremlau, M. H., & Sodroski, J. (2010) · Virology · doi:10.1016/j.virol.2010.09.019 · Cited by 38
Lin, J., Mendu, V., Pogany, J., Qin, J., & Nagy, P. D. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002491 · Cited by 36
Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation
Ciuffreda, D., Pantaleo, G., & Pascual, M. A. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00483.x · Cited by 35
CD147 stimulates HIV-1 infection in a signal-independent fashion
Pushkarsky, T., Yurchenko, V., Laborico, A., & Bukrinsky, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.192 · Cited by 34
ATPγS Disrupts Human Immunodeficiency Virus Type 1 Virion Core Integrity
Gurer, C., Höglund, A., Höglund, S., & Luban, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5557-5567.2005 · Cited by 36
Self-citationTripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis
Höglund, S., Su, J., Sandin, S., Végvári, Á., Hjertén, S., Sintorn, I., Foster, H., Wu, Y.-P., Nyström, I., & Vahlne, A. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3597-3605.2002 · Cited by 34
Gene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1
Chan, E., Towers, G. J., & Qasim, W. (2014) · Viruses · doi:10.3390/v6010243 · Cited by 42
Let me in: Control of HIV nuclear entry at the nuclear envelope
Bhargava, A., Lahaye, X., & Manel, N. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.02.006 · Cited by 35
How HIV-1 Gag Manipulates Its Host Cell Proteins: A Focus on Interactors of the Nucleocapsid Domain
Klingler, J., Anton, H., Réal, É., Zeiger, M., Moog, C., Mély, Y., & Boutant, E. (2020) · Viruses · doi:10.3390/v12080888 · Cited by 44
HIV-1 Capsid Core: A Bullet to the Heart of the Target Cell
Toccafondi, E., Lener, D., & Negroni, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.652486 · Cited by 33
Inhibition of HIV‐1 multiplication by a modified U7 snRNA inducing Tat and Rev exon skipping
Asparuhova, M. B., Marti, G., Liu, S., Serhan, F., Trono, D., & Schümperli, D. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1027 · Cited by 36
Mapping the stereospecificity of peptidyl prolyl cis/trans isomerases
Schiene, C., Reimer, U., Schutkowski, M., & Fischer, G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00871-0 · Cited by 33
Cyclophilin inhibitors as antiviral agents
Peel, M. R., & Scribner, A. W. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.101 · Cited by 32
Veillette, M., Bichel, K., Pawlica, P., Freund, S. M. V., Plourde, M. B., Pham, Q. T., Reyes‐Moreno, C., James, L. C., & Berthoux, L. (2013) · Retrovirology · doi:10.1186/1742-4690-10-25 · Cited by 32
Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type
Matsuoka, S., Dam, E., Lecossier, D., Clavel, F., & Hance, A. J. (2009) · Retrovirology · doi:10.1186/1742-4690-6-21 · Cited by 36
Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules
Vernekar, S. K. V., Sahani, R. L., Casey, M. C., Kankanala, J., Wang, L., Kirby, K. A., Du, H., Zhang, H., Tedbury, P. R., Xie, J., et al. (2020) · Viruses · doi:10.3390/v12040452 · Cited by 35
Species barrier of HIV‐1 and its jumping by virus engineering
Nomaguchi, M., Doi, N., Kamada, K., & Adachi, A. (2008) · Reviews in Medical Virology · doi:10.1002/rmv.576 · Cited by 35
Insights into the Roles of Cyclophilin A During Influenza Virus Infection
Liu, X., Zhao, Z., & Liu, W. (2013) · Viruses · doi:10.3390/v5010182 · Cited by 32
Host Genetics of HIV Acquisition and Viral Control
Shea, P. R., Shianna, K. V., Carrington, M. N., & Goldstein, D. B. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-052511-135400 · Cited by 36
Beauséjour, Y., & Tremblay, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11916-11925.2004 · Cited by 35
Control of Viral Infectivity by Tripartite Motif Proteins
Towers, G. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1125 · Cited by 38
Misumi, S., Fuchigami, T., Takamune, N., Takahashi, I., Takama, M., & Shoji, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.10000-10008.2002 · Cited by 32
Baba, M. (1997) · Antiviral Research · doi:10.1016/s0166-3542(96)01010-8 · Cited by 33
Recent advances in capillary electrophoresis/electrospray-mass spectrometry
von Brocke, A., NICHOLSON, G. J., & Bayer, E. (2001) · Electrophoresis · doi:10.1002/1522-2683(200105)22:7<1428::aid-elps1428>3.0.co;2-z · Cited by 197
Cyclosporins: immunosuppressive drugs with anti-HIV-1 activity
Thali, M. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)91208-8 · Cited by 31
Scholz, C., Scherer, G., Mayr, L. M., Schindler, T. H., Fischer, G. S., & Schmid, F. X. (1998) · Biological Chemistry · doi:10.1515/bchm.1998.379.3.361 · Cited by 32
Cyclophilin active site mutants have native prolyl isomerase activity with a protein substrate
Scholz, C., Schindler, T. H., Dolinski, K. J., Heitman, J., & Schmid, F. X. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00979-4 · Cited by 33
Nka, A. D., Bouba, Y., Této, G., Semengue, E. N. J., Takou, D., Ngueko, A. M. K., Fabeni, L., Carioti, L., Armenia, D., Pabo, W., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac388 · Cited by 33
Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV
Newton, L. S., Gathmann, C., Ridewood, S., Smith, R. J., Wijaya, A. J., Hornsby, T. W., Morling, K. L., Davison, D., Chiozzi, R. Z., Reuschl, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56317-8 · Cited by 41
MASS SPECTROMETRY IN VIROLOGICAL SCIENCES
Milewska, A., Ner‐Kluza, J., Dąbrowska, A., Bodzoń‐Kułakowska, A., Pyrć, K., & Suder, P. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21617 · Cited by 36
The Role of Capsid in HIV-1 Nuclear Entry
Guedán, A., Caroe, E. R., Barr, G. C. R., & Bishop, K. N. (2021) · Viruses · doi:10.3390/v13081425 · Cited by 33
Inhibition of Retroviral Replication by Members of the TRIM Protein Family
Fletcher, A. J., & Towers, G. J. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_2 · Cited by 36
A case study of proline isomerization in cell signaling
Min, L. (2005) · Frontiers in bioscience · doi:10.2741/1536 · Cited by 31
Wang, Z., Liu, X., Zhao, Z., Xu, C., Zhang, K., Chen, C., Sun, L., Gao, G. F., Ye, X., & Liu, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022625 · Cited by 33
Bosco, D. A., Eisenmesser, E. Z., Clarkson, M. W., Wolf‐Watz, M., Labeikovsky, W., Millet, Ó., & Kern, D. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.001 · Cited by 34
Sviben, D., Forčić, D., Kurtović, T., Halassy, B., & Brgles, M. (2016) · Archives of Virology · doi:10.1007/s00705-016-2801-3 · Cited by 29
Lavado‐García, J., Jorge, I., Boix‐Besora, A., Vázquez, J., Gòdia, F., & Cervera, L. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27786 · Cited by 36
Kootstra, N. A., Navis, M., Beugeling, C., van Dort, K. A., & Schuitemaker, H. (2007) · AIDS · doi:10.1097/qad.0b013e3282effa87 · Cited by 36
Nuss, J. E., Kehn‐Hall, K., Benedict, A., Costantino, J. A., Ward, M., Peyser, B. D., Retterer, C. J., Tressler, L. E., Wanner, L. M., McGovern, H. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093483 · Cited by 34
Cyclophilin A as negative regulator of apoptosis by sequestering cytochrome c
Bonfils, C., Bec, N., Larroque, C., Rio, M. D., Gongora, C., Pugnière, M., & Martineau, P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.135 · Cited by 30
Crystal Structure of NFAT Bound to the HIV-1 LTR Tandem κB Enhancer Element
Bates, D. L., Bjorkman, K. K., Wu, Y., Kalhor, R., Stroud, J. C., Giffin, M. J., & Chen, L. (2008) · Structure · doi:10.1016/j.str.2008.01.020 · Cited by 39
Wiegers, K. J., & Kräusslich, H. (2002) · Virology · doi:10.1006/viro.2001.1347 · Cited by 32
(2020) · doi:10.1039/c9sc04696h · Cited by 29
Watashi, K., & Shimotohno, K. (2007) · Europe PMC (PubMed Central) · Cited by 29
Campos-Olivas, R., & Summers, M. F. (1999) · Biochemistry · doi:10.1021/bi990991x · Cited by 29
Li, Q., Moutiez, M., Charbonnier, J., Vaudry, K., Ménèz, A., Quéméneur, É., & Dugave, C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9903139 · Cited by 29
Saphire, A. C. S., Bobardt, M. D., & Gallay, P. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4671-4677.2002 · Cited by 29
Immunopathogenesis of Human Immunodeficiency Virus: Implications for Immune‐Based Therapies
Sereti, I., & Lane, H. C. (2001) · Clinical Infectious Diseases · doi:10.1086/320758 · Cited by 29
Intercellular Adhesion Molecule 1 Promotes HIV-1 Attachment but Not Fusion to Target Cells
Kondo, N., & Melikyan, G. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044827 · Cited by 31
Zhao, C., Fang, C., Tian, X., Wang, L., Yang, P., & Wen, Y. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20945 · Cited by 28
Saphire, A. C. S., Bobardt, M. D., & Gallay, P. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2255-2262.2002 · Cited by 30
McCarthy, K. R., Schmidt, A. G., Kirmaier, A., Wyand, A. L., Newman, R. M., & Johnson, W. E. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003352 · Cited by 33
Novel HIV-1 capsid-targeting small molecules of the PF74 binding site
Wang, L., Casey, M. C., Vernekar, S. K. V., Sahani, R. L., Kankanala, J., Kirby, K. A., Du, H., Hachiya, A., Zhang, H., Tedbury, P. R., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112626 · Cited by 28
Tombusvirus-yeast interactions identify conserved cell-intrinsic viral restriction factors
Sasvári, Z., González, P. A., & Nagy, P. D. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00383 · Cited by 29
AKAP149 Binds to HIV-1 Reverse Transcriptase and Is Involved in the Reverse Transcription
Lemay, J., Maidou-Peindara, P., Cancio, R., Ennifar, E., Coadou, G., Maga, G., Rain, J., Bénarous, R., & Liu, L. X. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.055 · Cited by 27
Reconstitution of retroviral fusion and uncoating in a cell-free system
Narayan, S., & Young, J. A. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401312101 · Cited by 31
Structural Determinants of the Anti-HIV Activity of a CCR5 Antagonist Derived from Toxoplasma gondii
Yarovinsky, F., Andersen, J. F., King, L. R., Caspar, P., Aliberti, J., Golding, H., & Sher, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410550200 · Cited by 27
Late stages of the influenza A virus replication cycle—a tight interplay between virus and host
Pohl, M. O., Lanz, C., & Stertz, S. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000562 · Cited by 26
Saini, M., & Potash, M. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.443 · Cited by 27
Metadata
- Authors
- Franke, E. K., Yuan, H. E. H., & Luban, J.
- Affiliations
- Columbia University (US)
- ORCID
- Luban, Jeremy
- Venue
- Nature
- Published
- 1994-11
- Volume
- 372
- Issue
- 6504
- Pages
- 359-362
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2020597127
- Cited by
- 745
- References
- 28
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 9 · 2023: 16 · 2022: 7 · 2021: 13 · 2020: 16 · 2019: 12 · 2018: 13 · 2017: 10 · 2016: 18 · 2015: 19 · 2014: 28 · 2013: 25 · 2012: 32
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- cyclophilin A, HIV-1, Gag protein, viral assembly, peptidyl-prolyl isomerase, proline-rich region, host factors, HIV-1 replication
- MeSH terms
- Amino Acid Isomerases, Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Line, HeLa Cells, Humans, Molecular Sequence Data, Oligodeoxyribonucleotides, Transfection, Virion, Virus Replication, Simian Immunodeficiency Virus, HIV-1, Gene Products, gag, Mutagenesis, Peptidylprolyl Isomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.